Mannatech, Incorporated (NASDAQ:MTEX) Short Interest Update

Mannatech, Incorporated (NASDAQ:MTEX) was the target of a large growth in short interest during the month of May. As of May 15th, there was short interest totaling 41,501 shares, a growth of 62.2% from the April 30th total of 25,588 shares. Based on an average daily trading volume, of 86,348 shares, the days-to-cover ratio is presently 0.5 days. Approximately 3.7% of the shares of the company are sold short.

Mannatech Price Performance

NASDAQ:MTEX opened at $5.64 on Friday. The firm has a market cap of $10.89 million, a PE ratio of -0.84 and a beta of 0.72. Mannatech has a 12 month low of $3.80 and a 12 month high of $12.45. The company has a quick ratio of 0.59, a current ratio of 1.09 and a debt-to-equity ratio of 0.48. The company’s 50-day moving average price is $5.27 and its two-hundred day moving average price is $6.96.

Mannatech (NASDAQ:MTEX) last released its quarterly earnings results on Thursday, May 14th. The company reported $0.49 EPS for the quarter. Mannatech had a negative net margin of 11.97% and a negative return on equity of 2,383.34%. The firm had revenue of $24.92 million for the quarter.

Insider Transactions at Mannatech

In other news, Director Kevin Andrew Robbins bought 7,100 shares of the stock in a transaction that occurred on Tuesday, May 19th. The shares were acquired at an average cost of $4.17 per share, for a total transaction of $29,607.00. Following the purchase, the director owned 33,333 shares of the company’s stock, valued at $138,998.61. This represents a 27.07% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In the last quarter, insiders have acquired 14,903 shares of company stock valued at $62,155. Company insiders own 41.50% of the company’s stock.

Analysts Set New Price Targets

Separately, Weiss Ratings upgraded shares of Mannatech from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, May 26th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has an average rating of “Sell”.

About Mannatech

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.